Nursing

FDA pushes heparin recall measures

Nurse Leader Weekly, May 16, 2008

Want to receive articles like this one in your inbox? Subscribe to Nurse Leader Weekly!

The Food and Drug Administration (FDA) is putting heparin in the spotlight to increase awareness among healthcare professionals of injectable heparin products and flush solutions. Heparin products contaminated with oversulfated chondroitin sulfate were found at several facilities in a single state despite receiving recall instructions to rid them.

Because allergic or hypotensive symptoms due to heparin administration has lead to many reported deaths, the FDA is urging healthcare professionals and facilities to make certain all recalled heparin products have been eliminated.

The FDA suggests facilities examine drug and device storage areas, including emergency kits, dialysis units and automated drug storage cabinets. The FDA is also focusing on educating healthcare professionals on a number of medical devices and diagnostic products that may also contain or be coated with heparin, including certain intravascular catheters, oxygenators, and pumps.

Sources: American Nurses Association and U.S. Food and Drug Administration.



Want to receive articles like this one in your inbox? Subscribe to Nurse Leader Weekly!

Comments

0 comments on “FDA pushes heparin recall measures

 

Most Popular

Related Articles